At this stage in the negotiation process, we believe decisions are being made not only on dollars and cents, but also ego, strategy and a broader view of the competitive landscape. |
I suspect that Johnson & Johnson will be in the market sooner rather than later. |
I think J&J has a claim. I don't think they are going to have to pay Guidant. |
In our opinion this news is not new and should not slow down the merger with Guidant. |
Interestingly, (Boston Scientific) only raised its bid by $1, signaling that price is but one factor in the negotiation - but includes timeliness of closure. |
The good news is that this is not a recall, products are not being removed from hospital shelves, and no one has died. |
There's a phrase: to strike while the iron is hot. The iron is hot. |
They are playing chicken, and right now it appears that J&J has the upper hand. |
They're certainly making it harder for J&J to come back. Strategically we believe Boston Scientific with Guidant is a better match. |
We doubt this show is over, and in the end we expect that Boston Scientific will increase its bid. |
You know where you stand with him. Nothing is candy-coated. |